Pharmacokinetics and metabolism of [14C]BMS-820836 in healthy male subjects

Pharmacokinetics and metabolism of [14C]BMS-820836 in healthy male subjects - [14C] BMS-820836 ADME study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON34571

Enrollment

Registered

2010-10-25

Start date

2010-10-27

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anxiety disorders Depression

Interventions

Active substance: BMS-820836 and [14C]-BMS-820836

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: healthy male subjects, up to moderate smoking Age: 18-45 years BMI: 18.0-30.0 kg/m2

Exclusion criteria

Exclusion criteria: Suffering from: hepatitis B, cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 60 days from the start of the study or in case of donating more than 1 liter of blood in the 10 months prior the start of this study.

Design outcomes

Primary

Measure	Time frame
- Radiokinetics - Pharmacokinetics - Safety	—

Secondary

Measure	Time frame
N.a.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)